Patents Assigned to PepTC Vaccines Limited
  • Coronavirus vaccine
    Patent number: 10973909
    Abstract: The disclosure relates to polypeptides, vaccines and pharmaceutical compositions that find use in the prevention or treatment of Coronaviridae or SARS-CoV-2 infection. The disclosure also relates to methods of treating or preventing Coronaviridae or SARS-CoV-2 infection in an individual. The polypeptides and vaccines comprise T cell and/or B cell epitopes that are immunogenic in a high percentage of individuals in the human population.
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: April 13, 2021
    Assignee: PepTC Vaccines Limited
    Inventors: Zsolt Csiszovszki, Orsolya Lörincz, Levente Molnár, Péter Páles, Katalin Pántya, Eszter Somogyi, József Tóth, Enikö R. Töke